Marketing - Press Releases

Date	Title	Company
06-Dec-2019	First Clinical Study Evaluating Combined tDCS And Behaviour Therapy Could Point To A New Treatment For Depression	Flow Neuroscience
05-Dec-2019	Inceptua appoints new President North America	Inceptua
05-Dec-2019	Lessons from EU Medical Device Regulation compliance preparations	Kallik
04-Dec-2019	New global survey shows misperceptions about lung cancer among the general public	Lung Ambition Alliance
04-Dec-2019	ASLAN PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES	ASLAN Pharmaceuticals
04-Dec-2019	Volker Koscielny, new Chief Medical Officer and new member of the Management Board at Almirall	Almirall
04-Dec-2019	Interview Released Stefan Przyborski, Chairman for SMi’s 3D Cell Culture Conference 2020	SMi Group
04-Dec-2019	Chiesi outlines €350 million investment and announces the development of the first carbon minimal pressurised Metered Dose Inhaler (pMDI) for Asthma and COPD	Chiesi Group
04-Dec-2019	Kancera reports in-depth analysis of the Phase Ib program with KAND567, showing the desired effect on the human immune system	Kancera AB
04-Dec-2019	MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs	MaxCyte, Inc.
04-Dec-2019	MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs	MaxCyte
03-Dec-2019	Owkin teams up with NVIDIA and King's College London to deliver AI to hospitals while protecting patient data with Federated Learning	Owkin
03-Dec-2019	Cancer – New Inhibitor Effective Where Others Fail	Karl Landsteiner University of Health Sciences
03-Dec-2019	Announces Distribution Agreement with Apex	Ascension Healthcare plc
03-Dec-2019	ASLAN PHARMACEUTICALS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES	ASLAN Pharmaceuticals
02-Dec-2019	Confo Therapeutics reports grant of two key patents for ConfoBodies™	Confo Therapeutics
02-Dec-2019	Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop	Destiny Pharma plc
02-Dec-2019	Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies	Cambridge Innovation Capital
02-Dec-2019	Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer	Ergomed plc
02-Dec-2019	ABPI appoints Dr Richard Torbett as new Chief Executive	The Association of the British Pharmaceutical Industry (ABPI)